The emerging therapy of the medication represents a exciting advance in the management of type 2 diabetes. Different to existing medications, tirzepatide affects two pathways – glucagon-like peptide-1 (GLP-1) and GIP https://tirzepatidepeptide642202.mybjjblog.com/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment-54201451